Myung In Pharmaceutical LTD. (KRX:317450)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Pharmaceutical			239.42B	223.25B	207.85B	187.84B	180.14B
Real Estate Rental			3.08B	2.77B	1.60B	33.67M	1.64B
Advertising Agency			3.30B	2.66B	3.37B	3.53B	2.60B
Consolidation Adjustment			-3.46B	-2.85B	-3.57B	-3.57B	-2.60B
Total			242.34B	225.83B	209.25B	187.84B	181.79B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
South Korea			242.34B	225.83B	209.25B	187.84B	181.79B
Total			242.34B	225.83B	209.25B	187.84B	181.79B

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error